SHANG.FOS.PHARM.GR.H YC 1 - Asset Resilience Ratio

Latest as of March 2026: 1.81%

SHANG.FOS.PHARM.GR.H YC 1 (08HH) has an Asset Resilience Ratio of 1.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore SHANG.FOS.PHARM.GR.H YC 1 balance sheet assets for the complete picture of this company's asset base.

Liquid Assets

€2.23 Billion

≈ $2.60 Billion USD Cash + Short-term Investments

Total Assets

€122.97 Billion

≈ $143.76 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how SHANG.FOS.PHARM.GR.H YC 1's Asset Resilience Ratio has changed over time. See net asset quality index of SHANG.FOS.PHARM.GR.H YC 1 to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down SHANG.FOS.PHARM.GR.H YC 1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SHANG.FOS.PHARM.GR.H YC 1 stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.23 Billion	1.81%
Total Liquid Assets	€2.23 Billion	1.81%

Asset Resilience Insights

Limited Liquidity: SHANG.FOS.PHARM.GR.H YC 1 maintains only 1.81% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

SHANG.FOS.PHARM.GR.H YC 1 Industry Peers by Asset Resilience Ratio

Compare SHANG.FOS.PHARM.GR.H YC 1's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	Drug Manufacturers - Specialty & Generic	2.09%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.15%

Annual Asset Resilience Ratio for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for SHANG.FOS.PHARM.GR.H YC 1.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.88%	€2.25 Billion ≈ $2.64 Billion	€120.05 Billion ≈ $140.36 Billion	-0.33pp
2024-12-31	2.21%	€2.60 Billion ≈ $3.03 Billion	€117.46 Billion ≈ $137.32 Billion	+0.55pp
2023-12-31	1.66%	€1.89 Billion ≈ $2.21 Billion	€113.47 Billion ≈ $132.66 Billion	+0.80pp
2022-12-31	0.87%	€928.53 Million ≈ $1.09 Billion	€107.16 Billion ≈ $125.29 Billion	-3.68pp
2021-12-31	4.55%	€4.24 Billion ≈ $4.96 Billion	€93.31 Billion ≈ $109.08 Billion	--

pp = percentage points

About SHANG.FOS.PHARM.GR.H YC 1

F:08HH Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.19 Billion

€1.02 Billion EUR

Market Cap Rank

#8389 Global

#1100 in Germany

Share Price

€1.84

Change (1 day)

+0.55%

52-Week Range

€1.66 - €3.22

All Time High

€4.65